Loading clinical trials...
Loading clinical trials...
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions
Conditions
Interventions
losartan potassium hydrochlorothiazide
Locations
1
United States
CEDRA Clinical Research, LLC
Austin, Texas, United States
Start Date
February 1, 2005
Primary Completion Date
March 1, 2005
Completion Date
March 1, 2005
Last Updated
January 23, 2018
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Roxane Laboratories
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions